Market Overview

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue

Related FRX
Activis Shares Languish Post-Forest Deal
Among A Raft Of Index Changes, Affiliated Managers Group To Join S&P 500
Forest Labs to Buy Furiex Pharma in $1.5B Deal (Fox Business)
Related ENDP
Jazz Pharmaceuticals (JAZZ) in Focus: Stock Surges 8.8% - Tale of the Tape
Jazz Pharmaceuticals (JAZZ) Jumps: Stock Moves 5.2% Higher - Tale of the Tape

Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of revenue.

The trailing-twelve-month revenue at Forest Laboratories (NYSE: FRX) is $3.82 billion. Forest Laboratories' ROE for the same period is 9.98%.

The trailing-twelve-month revenue at Endo Health Solutions (NASDAQ: ENDP) is $3.03 billion. Endo Health's PEG ratio is 0.90.

The trailing-twelve-month revenue at Warner Chilcott plc (NASDAQ: WCRX) is $2.58 billion. Warner Chilcott had $304.00 million in total cash for the latest quarter.

The trailing-twelve-month revenue at Dr. Reddy's Laboratories (NYSE: RDY) is $2.05 billion. Dr. Reddy's operating margin for the same period is 20.84%.

Posted-In: Drug Manufacturers-Other Industry Highest Revenue Mid-CapTrading Ideas

 

Related Articles (ENDP + FRX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters